These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A clinicopathological study of peripheral, small-sized high-grade neuroendocrine tumours of the lung: differences between small-cell lung carcinoma and large-cell neuroendocrine carcinoma. Isaka M; Nakagawa K; Ohde Y; Okumura T; Watanabe R; Ito I; Nakajima T; Kondo H Eur J Cardiothorac Surg; 2012 Apr; 41(4):841-6. PubMed ID: 22219429 [TBL] [Abstract][Full Text] [Related]
24. P63 expression in lung carcinoma: a tissue microarray study of 408 cases. Au NH; Gown AM; Cheang M; Huntsman D; Yorida E; Elliott WM; Flint J; English J; Gilks CB; Grimes HL Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):240-7. PubMed ID: 15551738 [TBL] [Abstract][Full Text] [Related]
25. Expression of Bcl-2 in lung neuroendocrine tumours: comparison with p53. Wang DG; Johnston CF; Sloan JM; Buchanan KD J Pathol; 1998 Mar; 184(3):247-51. PubMed ID: 9614375 [TBL] [Abstract][Full Text] [Related]
26. Accelerated apoptosis and low bcl-2 expression associated with neuroendocrine differentiation predict shortened survival in operated large cell carcinoma of the lung. Eerola AK; Ruokolainen H; Soini Y; Raunio H; Pääkkö P Pathol Oncol Res; 1999; 5(3):179-86. PubMed ID: 10491014 [TBL] [Abstract][Full Text] [Related]
27. Immunohistochemical analysis of OTP and NKX6.1 in neuroendocrine tumors of the lung and pancreas. Yoxtheimer LM; Heymann JJ; Cohen C; Rao RA; Goyal A; Siddiqui MT Diagn Cytopathol; 2018 Dec; 46(12):1010-1014. PubMed ID: 30284410 [TBL] [Abstract][Full Text] [Related]
28. Automated quantification of Ki-67 proliferative index of excised neuroendocrine tumors of the lung. Liu SZ; Staats PN; Goicochea L; Alexiev BA; Shah N; Dixon R; Burke AP Diagn Pathol; 2014 Oct; 9():174. PubMed ID: 25318848 [TBL] [Abstract][Full Text] [Related]
29. Promyelocytic leukemia zinc finger and histone H1.5 differentially stain low- and high-grade pulmonary neuroendocrine tumors: a pilot immunohistochemical study. Hechtman JF; Beasley MB; Kinoshita Y; Ko HM; Hao K; Burstein DE Hum Pathol; 2013 Jul; 44(7):1400-5. PubMed ID: 23416030 [TBL] [Abstract][Full Text] [Related]
30. Head and neck large cell neuroendocrine carcinoma should be separated from atypical carcinoid on the basis of different clinical features, overall survival, and pathogenesis. Kao HL; Chang WC; Li WY; Chia-Heng Li A; Fen-Yau Li A Am J Surg Pathol; 2012 Feb; 36(2):185-92. PubMed ID: 22082601 [TBL] [Abstract][Full Text] [Related]
31. Primary large-cell neuroendocrine carcinoma of the parotid gland: immunohistochemical and molecular analysis of two cases. Nagao T; Sugano I; Ishida Y; Tajima Y; Munakata S; Asoh A; Yamazaki K; Muto H; Konno A; Kondo Y; Nagao K Mod Pathol; 2000 May; 13(5):554-61. PubMed ID: 10824928 [TBL] [Abstract][Full Text] [Related]
32. The diagnostic utility of zinc E-box 1 (ZEB1) transcription factor for identification of pulmonary sarcomatoid carcinoma in cytologic and surgical specimens. Viswanathan K; Siddiqui MT; Borczuk AC J Am Soc Cytopathol; 2020; 9(1):55-61. PubMed ID: 31677963 [TBL] [Abstract][Full Text] [Related]
33. Chromosomal aberrations in a series of large-cell neuroendocrine carcinomas: unexpected divergence from small-cell carcinoma of the lung. Ullmann R; Petzmann S; Sharma A; Cagle PT; Popper HH Hum Pathol; 2001 Oct; 32(10):1059-63. PubMed ID: 11679939 [TBL] [Abstract][Full Text] [Related]
34. Analysis of protein expression and gene mutation of c-kit in colorectal neuroendocrine carcinomas. Akintola-Ogunremi O; Pfeifer JD; Tan BR; Yan Y; Zhu X; Hart J; Goldblum JR; Burgart L; Lauwers GY; Montgomery E; Lewin D; Washington K; Bronner M; Xiao SY; Greenson JK; Lamps L; Lazenby A; Wang HL Am J Surg Pathol; 2003 Dec; 27(12):1551-8. PubMed ID: 14657715 [TBL] [Abstract][Full Text] [Related]
35. [Pulmonary neuroendocrine tumors in the new WHO 2015 classification: Start of breaking new grounds?]. Schnabel PA; Junker K Pathologe; 2015 May; 36(3):283-92. PubMed ID: 25956813 [TBL] [Abstract][Full Text] [Related]
36. Different expression of EZH2, BMI1 and Ki67 in low and high grade neuroendocrine tumors of the lung. Bondgaard AL; Poulsen TT; Poulsen HS; Skov BG Cancer Biomark; 2012; 11(2-3):123-8. PubMed ID: 23011159 [TBL] [Abstract][Full Text] [Related]
37. Typical and atypical carcinoid tumors of the lung are characterized by 11q deletions as detected by comparative genomic hybridization. Walch AK; Zitzelsberger HF; Aubele MM; Mattis AE; Bauchinger M; Candidus S; Präuer HW; Werner M; Höfler H Am J Pathol; 1998 Oct; 153(4):1089-98. PubMed ID: 9777940 [TBL] [Abstract][Full Text] [Related]
38. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis. Yaren A; Oztop I; Kargi A; Ulukus C; Onen A; Sanli A; Binicier O; Yilmaz U; Alakavuklar M Int J Clin Pract; 2006 Jun; 60(6):675-82. PubMed ID: 16805752 [TBL] [Abstract][Full Text] [Related]
39. The prognostic role of c-kit protein expression in resected large cell neuroendocrine carcinoma of the lung. Casali C; Stefani A; Rossi G; Migaldi M; Bettelli S; Parise A; Morandi U Ann Thorac Surg; 2004 Jan; 77(1):247-52; discussion 252-3. PubMed ID: 14726070 [TBL] [Abstract][Full Text] [Related]
40. Expression of L-type amino acid transporter 1 (LAT1) in neuroendocrine tumors of the lung. Kaira K; Oriuchi N; Imai H; Shimizu K; Yanagitani N; Sunaga N; Hisada T; Kawashima O; Iijima H; Ishizuka T; Kanai Y; Endou H; Nakajima T; Mori M Pathol Res Pract; 2008; 204(8):553-61. PubMed ID: 18440724 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]